Survival after neoadjuvant approaches to gastroesophageal junction cancer
Sign Up to like & getrecommendations! Published in 2019 at "Gastric Cancer"
DOI: 10.1007/s10120-019-00980-6
Abstract: Background Gastroesophageal junction (GEJ) cancers can be treated with equipoise using neoadjuvant chemoradiation (NACRT) or chemotherapy alone (NAC), but the comparative outcomes are unclear. Methods Patients with non-metastatic T2-4 or N1-3 GEJ adenocarcinoma who underwent… read more here.
Keywords: chemotherapy; gastroesophageal junction; cancer; nacrt nac ... See more keywords